期刊文献+

脂质代谢异常与恶性肿瘤相关性研究进展 被引量:3

Research progress on the relationship between dyslipidemia and malignant tumor
原文传递
导出
摘要 代谢在生命活动及疾病发生发展中有特别重要的作用。肿瘤患者存在明显的脂质代谢异常,脂质代谢的异常过程通过调节信号传导通路影响基因和蛋白的异常表达,促进细胞恶性转化、侵袭和转移,抑或起到相反的作用,不同肿瘤患者的脂质代谢特点不同。笔者综述了脂质代谢异常与恶性实体肿瘤相关性的基础研究和流行病学研究进展,对恶性肿瘤的预防、治疗以及判断预后等提供帮助。 Lipid metabolism plays an important role in the development of life activities and disease.Lipid metabolism is obviously abnormal in patients with tumor disease.It regulates the abnormal expression of genes and proteins by affecting the signal transduction pathway,thus the outcome is promoting transformation,invasion and metastasis of malignant cells,or playing an opposite role.Characteristics of lipid metabolism are different among patients with different tumors.The writer reviewed the research progress of basic and epidemiological studies on the relationship between lipid metabolism and malignant tumors,aimed to prevent,treat and judge the prognosis of malignant tumors.
作者 苑小星 Yuan Xiaoxing(Department of Hematology and Oncology,Pinggu Hospital of Beijing Friendship Hospital,Capital Medical University,Beijing 101200,China)
出处 《中国基层医药》 CAS 2020年第18期2300-2304,共5页 Chinese Journal of Primary Medicine and Pharmacy
关键词 脂质代谢异常 流行病学研究 恶性肿瘤 异常表达 恶性实体肿瘤 侵袭和转移 信号传导通路 肿瘤患者 Neoplasms Lipid metabolism Membrane microdomains Adiponectin Review
  • 相关文献

参考文献4

二级参考文献69

  • 1韩存芝,杜丽莉,刘秀英,荆洁线,赵先文,田保国.血清瘦素及脂类水平与乳腺癌的相关性研究[J].营养学报,2005,27(5):378-381. 被引量:8
  • 2Masafumi Tabuchi,Joji Kitayama,Hirokazu Nagawa.Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men[J].World Journal of Gastroenterology,2006,12(8):1261-1264. 被引量:13
  • 3Hu NC, Chen JD, Lin YM, et al. Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwan Residents population receiving screening colonoscopy. J Formos Med Assoc, 2011,110: 100-108.
  • 4Lee MY, Lin KD, Hsiao PJ, et al. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwan Residents patients. Metabolism, 2012,61 : 242-249.
  • 5Coogan PF, Smith J, Rosenberg L. Statin use and the risk of colorectal cancer. J Natl Cancer Inst, 2007,99:32-40.
  • 6Setoguchi S, Glynn R J, Avorn J, et al. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation, 2007,115 : 27-33.
  • 7Bonovas S, Filioussi K, Flordellis CS, et al. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol, 2007,25 : 3462-3468.
  • 8Jin H, Yang Z, Wang J, et al. A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor. Tumour Biol, 2011,32 : 391-397.
  • 9Kolinsky K, Zhang YE, Dugan U, et al. Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts. Anticancer Res, 2009,29 : 91-98.
  • 10Kodach LL, Jacobs RJ, Voorneveld PW, et al. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'sternness' via the bone morphogenetic protein pathway. Gut,2011,60:1544-1553.

共引文献33

同被引文献37

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部